Óscar Millet

Dr. Millet holds degrees in Chemistry (Univ. Ramon Llull, 1994) and Chemical Engineering (IQS, 1995). After obtaining a PhD in Organic Chemistry (University of Barcelona, 1999) he joined the Lewis Kay group in Toronto for a post-doctoral stay (University of Toronto, 2000-2004). He was then recipient of a Ramon y Cajal reincorporation contract at the Parc Cientific de Barcelona (2004-2006), and is currently group leader at the CIC bioGUNE. His research focuses on the use of nuclear magnetic resonance (NMR) in the study of biologically relevant proteins and enzymes, particularly the delicate balance between protein stability and dynamics. Such knowledge is applied in the development of new compounds with therapeutic activity, specifically in the field of rare diseases. He has published more than 125 papers with over 5500 citations (1998-2025) and an h-index of 33. He was the Spanish delegate for the trans domain of the COST program (2009-2014). He was awarded the Elhuyar-Goldschmidt Lecture Award of the GDCh (2022), the prize of the Real Sociedad Española de Química (2004) and the Spanish NMR group prize (2005). He currently is the president of the Spanish Chemical Biology group.